FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer Following Landmark Clinical Trial Led by Dana-Farber

GLP-1 Medications and Cancer Risk: What We Know So Far

Singer, Actress Finds New Way
to Use Her Voice After
Colorectal Cancer  

FDA Approves First CELMoD Agent, With Dana-Farber Helping Advance Its Development

What is the Difference
Between Gene Therapy
and Immunotherapy?

More Cancer Research Stories

Cancer Questions
with Dana-Farber

Make an Appointment

Adult: 877-442-3324

Pediatric: 888-733-4662

Other Inquiries >

Support Our Mission to Defy Cancer

Become a monthly donor today. Your first year of monthly gifts will be TRIPLE MATCHED to support cancer research and care—and you’ll receive special benefits.

Join us on October 4 as we walk together against cancer at the Jimmy Fund Walk for Dana-Farber!

You can help sustain our lifesaving research and care while getting tax savings and fixed income for life. Discover more about charitable gift annuities, a tax-smart gift that gives back.

Feedback

© Dana-Farber Cancer Institute

450 Brookline Avenue, Boston, 02215

dana-farber.org

Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.

450 Brookline Ave. | Boston, MA 02215 US